Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 1511

Ohh nice! New vaccine science it seems though I’m not familiar with vaccines, this does seem like a novel approach. It’s kinda future proof to train the immune system to target proteins that are shared across all coronavirus’ I’m hoping it provides, as do they, that it provides a better solution than current vaccines.

The vaccine is made by attaching harmless proteins from different coronaviruses to minuscule nanoparticles that are then injected to prime the body’s defences to fight the viruses should they ever invade.

Because the vaccine trains the immune system to target proteins that are shared across many different types of coronavirus, the protection it induces is extremely broad, making it effective against known and unknown viruses in the same family.

“We’ve shown that a relatively simple vaccine can still provide a scattershot response across a range of different viruses,” said Rory Hills, a graduate researcher at the University of Cambridge and first author of the report. “It takes us one step forward towards our goal of creating vaccines before a pandemic has even started.”

Continue reading “Scientists create vaccine with potential to protect against future coronaviruses” | >

The AI of the future won’t just be a chatbot — it’ll be, according to OpenAI CEO Sam Altman, outfitted with incredibly detailed information about its users.

In an interview with the MIT Technology Review, Altman suggested that AI should be working for its users harder than even the hardest-working human executive assistant, and would know absolutely everything about whoever is using it.

Speaking to the magazine between a series of events at Harvard, which were hosted in part by the venture capital firm Xfund, the OpenAI cofounder said that the best use of AI would be a “super-competent colleague that knows absolutely everything about my whole life, every email, every conversation I’ve ever had, but doesn’t feel like an extension.”

Read more | >

The original version of this story appeared in Quanta Magazine.

In October, a Falcon Heavy rocket is scheduled to launch from Cape Canaveral in Florida, carrying NASA’s Europa Clipper mission. The $5 billion mission is designed to find out if Europa, Jupiter’s fourth-largest moon, can support life. But because Europa is constantly bombarded by intense radiation created by Jupiter’s magnetic field, the Clipper spacecraft can’t orbit the moon itself. Instead, it will slide into an eccentric orbit around Jupiter and gather data by repeatedly swinging by Europa—53 times in total—before retreating from the worst of the radiation. Every time the spacecraft rounds Jupiter, its path will be slightly different, ensuring that it can take pictures and gather data from Europa’s poles to its equator.

To plan convoluted tours like this one, trajectory planners use computer models that meticulously calculate the trajectory one step at a time. The planning takes hundreds of mission requirements into account, and it’s bolstered by decades of mathematical research into orbits and how to join them into complicated tours. Mathematicians are now developing tools which they hope can be used to create a more systematic understanding of how orbits relate to one another.

Read more | >

Serial home tests would reduce unnecessary colonoscopy testing. Patients with suspected inflammatory bowel disease (IBD) could benefit from better testing protocols that would reduce the need and lengthy wait for potentially unnecessary colonoscopies, a new study has found.

In a paper published in Frontline Gastroenterology, researchers from the Birmingham NIHR Biomedical Research Centre (BRC) at the University of Birmingham tested a new protocol to improve IBD diagnosis combining clinical history with multiple home stool tests.

In the two-year study involving 767 participants, patients were triaged and had repeated faecal calprotectin (FCP) tests and the research team found that the use of serial FCP tests were able to strongly predict possible IBD as well as Crohn’s Disease and Ulcerative Colitis.

Read more | >